Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Feasibility and Effectiveness of 4th Generation Bipolar Radiofrequency Endometrial Ablation Device: a Cohort Study

NCT02449304 is registered in ClinicalTrials.gov with Birmingham Women's NHS Foundation Trust as lead sponsor.

NCT NCT02449304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02449304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Feasibility and Effectiveness of 4th Generation Bipolar Radiofrequency Endometrial Ablation Device: a Cohort Study
Lead sponsor
Birmingham Women's NHS Foundation Trust
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2015
Completion date
April 30, 2020
Enrollment
50 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heavy menstrual bleeding